April 27 (Reuters) - Telix Pharmaceuticals Ltd TLX.AX :
* TELIX PHARMACEUTICALS LTD - ENTERS INTO EXCLUSIVE LICENCE AGREEMENT WITH OSAKA UNIVERSITY
* TELIX PHARMACEUTICALS LTD - AGREEMENT TO DEVELOP SECOND-GENERATION VARIANTS OF TLX101 (131I-IPA) FOR CERTAIN ADVANCED CANCER THERAPY APPLICATIONS